Recent advances in genetic testing can help to provide a specific diagnosis to children born with syndromes that result in congenital anomalies and developmental delay. One such emerging condition is the 22q13 deletion syndrome. With the introduction of subtelomeric fluorescence-in-situ hybridization (FISH) analysis, the 22q13 deletion has become recognized as a relatively widespread and underdiagnosed cause of mental retardation. Primary-care physicians play an important role in the care of children with 22q13 deletion syndrome, from suspecting the diagnosis in a developmentally delayed child through the medical, developmental, and behavioral aspects of their care. Furthermore, they serve as a valuable source of support and advocacy for the family and a resource for other care providers. The remainder of this article addresses the current state of knowledge regarding 22q13 deletion syndrome and offers the primary-care physician a framework in which to provide care and information.
Get full access to this article
View all access options for this article.
References
1.
Flint J, Wilke AOM, Buckle VJ, et al.The detection of subtelomeric chromosomal rearrangements in idiopathic mental retardation. Nature Genet. 1995;9:132-140.
2.
Watt JL, Olson IA, Johnston AW, et al.A familial pericentric inversion of chromosome 22 with recombinant subject illustrating a ‘pure’ partial monosomy syndrome. J Med Genet. 1985;22:283-287.
3.
Nesslinger NJ, Gorski JL, Kurczynski TW, et al.Clinical, cytogenetic, and molecular characterization of seven patients with deletion of chromosome 22q13.3. Am J Hum Genet. 1994;54:464-472.
4.
Precht KS, Lese CM, Spiro RP, et al.Two 22q telomere deletions serendipitously detected by FISH. J Med Genet. 1998;35:939-942.
5.
Goizet C, Excoffier E, Taine L, et al.Case with autistic syndrome and chromosome 22q13.3 deletion detected by FISH. Am J Med Genet. 2000;96:839-844.
6.
Prasad C, Prasad AN, Chodirker BN, et al.Genetic evaluation of pervasive developmental disorders: the terminal 22q13 deletion syndrome may represent a recognizable phenotype. Clin Genet. 2000;92:195-199.
7.
de Vries BB, Bitner-Glindzicz M, Knight SJ, et al.A boy with submicroscopic 22qter deletion, general over-growth and features suggestive of FG syndrome. Clin Genet. 2000;58:483-487.
8.
Phelan MC, Rogers RC, Saul RA, et al.22q13 deletion syndrome. Am J Med Genet. 2001;101:91-99.
9.
Phelan MC, Rogers RC, Stevenson RE. A de-novo terminal deletion of 22q. Am J Hum Genet. 1988;43:A118.
10.
Anderlid BM, Schoumans J, Anneren G, et al.FISH mapping of a 100-kb terminal 22q13 deletion. Hum Genet. 2002;110:439-443.
11.
Romain DR, Goldsmith J, Cairney H, et al.Partial monosomy for chromosome 22 in a patient del(22)(pter→q13.1::q13.33→qter). J Med Genet. 1990;27:588-589.
12.
Fujita Y, Mochizuki D, Mori Y, et al.Girl with accelerated growth, hearing loss, inner ear anomalies, delayed myelination of the brain, and del(22)(q13.1q13.2). Am J Med Genet. 2000;92:195-199.
13.
Slavotinek A, Maher E, Gregory P, et al.The phenotypic effects of chromosome rearrangement involving bands 7q21.3 and 22q13.3. J Med Genet. 1997;34:857-861.
14.
Yong YP, Knight LA, Yong MH, et al.Partial monosomy for chromosome 22 in a girl with mental retardation. Singapore Med J. 1997;38:85-86.
15.
Wong ACC, Ning Y, Flint J, et al.Molecular characterization of a 130-kb terminal microdeletion at 22q in a child with mild mental retardation. Am J Hum Genet. 1997;60:113-120.
16.
Bonagalia MC, Giorda R, Borgatti R, et al.Disruption of the ProSAP2gene in a t(12;22)(q24.1;q13.3) is associated with the 22q13.3 deletion syndrome. Am J Hum Genet. 2001;69:261-268.
17.
Narahara K, Takahashi Y, Murakami M, et al.Terminal 22q deletion associated with a partial deficiency of arylsulphatase A. J Med Genet. 1992;29:432-433.
18.
Phelan MC, Thomas GR, Saul RA, et al.Cytogenetic, biochemical and molecular analysis of a 22q13 deletion. Am J Med Genet. 1992;43:872-876.
19.
Smith A, Jauch A, St Heaps L, et al.Unbalanced translocation t(15:22) in “severe” Prader-Willi syndrome. Ann Genet. 2000;43:125-130.
20.
Wilson HL, Wong ACC, Shaw SR, et al.Molecular characterization of the 22q13 deletion syndrome supports the role of haploinsufficiency of SHANK3/PROSAP2 in the major neurological symptoms. J Med Genet. 2003;40:575-584.
21.
Ziff EB. Enlightening the post synaptic density. Neuron. 1997;19:1163-1174.
22.
Boeckers TM, Winter C, Smalla K-H, et al.Prolin-rich synapse-associated proteins ProSAP1 and ProSAP2 interact with synaptic proteins of SAPAP/GKAP family. Biochem Biophys Res Commun. 1999;264:247-252.
23.
Kennedy MB. Signal-processing machines at the post synaptic density. Science. 2000;290:750-754.
24.
Chelly J. Breakthroughs in molecular and cellular mechanisms underlying X-linked mental retardation. Hum Mol Genet. 1999;8:1833-1838.
Schroder K, Schuffenhauser S, Seidel H, et al.Deletion mapping by FISH with BACs in patients with partial monosomy 22q13. Hum Genet. 1998;102:557-561.
27.
Herman GE, Greenberg F, Ledbetter DH. Multiple congenital anomaly/mental retardation (MCA/MR) syndrome with a Goldenhar complex due to a terminal del(22q). Am J Med Genet. 1988;29:909-915.
28.
Epstein CJ. The Consequences of Chromosome Imbalance—Principles, Mechanisms, and Models. Cambridge, UK: Cambridge University Press; pp. 13-15, 177-183, 1986.
29.
Laan LAEM, Renier WO, Arts WFM, et al.Evolution of epilepsy and EEG findings in Angelman syndrome. Epilepsia. 1997;38:195-199.
30.
de Vries BB, Tyson J, Winter RM, Malcom S. No evidence for submicroscopic 22qter deletions with features suggestive for Agelman syndrome. Am J Med Genet. 2002;109:117-120.
31.
Praphanphoj V, Goodman BK, Thomas GH, Raymond GV. Cryptic subtelomeric translocations in the 22q13 deletion syndrome. J Med Genet. 2000;37:58-61.
32.
Pearlson GD, Breiter SN, Alward EH, et al.MRI brain changes in subjects with Down syndrome with and without dementia. Dev Med Child Neurol. 1998;40:326-334.
33.
Petiti N, Holder CA, Williams DW III.Mucopolysaccharideosis III (Sanfilippo syndrome) type B: cranial imaging in two cases. Comput Assist Tomogr. 1997;21:897-899.
34.
Wadsby M, Lindehammer H, Eegolofsson O. Neurofibromatosis in childhood. Neuropsychological aspects. Neurofibromatosis. 1989;2:251-260.
35.
Wang PJ, Lin HC, Liu HM, et al.Intracranial arachnoid cysts in children related signs and associated anomolies. Pediatr Neurol. 1998;12:100-104.
36.
Doheny KF, McDermid HE, Harum K, et al.Cryptic terminal rearrangement of chromosome 22q13.32 detected by FISH in two unrelated patients. J Med Genet. 1997;34:640-644.
37.
Zwaigenbaum L, Siegel-Bartelt J, Teshima I, Ho C. Two patients with 22q13.3 deletions have similar facies and developmental patterns. Am J Hum Genet. 1990;47:A45.
38.
Wilhelm H, Lovas OI. Stimulus overselection: a common feature in autism and mental retardation. Am J Mental Defic. 1976;81:227-241.
